Alerts will be sent to your verified email
Verify Email
LYPSAGEMS
|
Lypsa Gems
|
Samyak International
|
Rubra Medicaments
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-27.7 % | 1.23 % | -2.03 % |
|
5yr average Equity Multiplier
|
2.37 | 1.43 | 1.44 |
|
5yr Average Asset Turnover Ratio
|
0.4 | 0.4 | 1.44 |
|
5yr Avg Net Profit Margin
|
-132.74 % | 1.7 % | -0.31 % |
|
Price to Book
|
1.21 | 0.36 | 35.84 |
|
P/E
|
0.0 | 0.0 | 223.95 |
|
5yr Avg Cash Conversion Cycle
|
1910.48 Days | -79.6 Days | 183.71 Days |
|
Inventory Days
|
17.1 Days | 82.16 Days | 0.0 |
|
Days Receivable
|
3586.85 Days | 68.76 Days | 183.71 Days |
|
Days Payable
|
2006.22 Days | 214.47 Days | 33.56 Days |
|
5yr Average Interest Coverage Ratio
|
54.4 | 2.64 | -248.31 |
|
5yr Avg ROCE
|
-27.35 % | 2.62 % | -2.28 % |
|
5yr Avg Operating Profit Margin
|
-64.99 % | 10.46 % | -0.3 % |
|
5 yr average Debt to Equity
|
0.16 | 0.17 | 0.06 |
|
5yr CAGR Net Profit
|
n/a | n/a | 0.0 |
|
5yr Average Return on Assets
|
-13.21 % | 1.0 % | -1.63 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
36.37 % | 22.35 % | 0.0 |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 13.17 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Lypsa Gems
|
Samyak International
|
Rubra Medicaments
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|